Coverage
-
March 10, 2017
A New York federal judge Thursday consolidated two end-payer cases in a proposed class action alleging that drugmakers conspired to jack up the price of generic blood pressure medication propranolol, and rejected a motion for separate trials for cases filed by direct purchasers.
2 other articles on this case.
View all »